Clinical Trial of EPASS With Hot AXIOS System (PASSAGE)
Gastric Outlet Obstruction
About this trial
This is an interventional supportive care trial for Gastric Outlet Obstruction
Eligibility Criteria
Inclusion Criteria: Unresectable malignant duodenal obstruction confirmed by biopsy Eligible for endoscopic intervention GOOSS score of 0 or 1 18 years of age or older Willing and able to comply with the study procedures or legally authorized representative (LAR) must provide written informed consent form (ICF) to participate in the study Exclusion Criteria: GOO symptoms are not expected to improve after the index procedure Life expectancy is about 3 months or less, which is not assumed applicable for surgical GJ Prior metallic stent placement for GOO Contraindicated to surgery and general anesthesia Neoplasm invading the target site of puncture in gastric and/or jejunum Abnormal coagulation INR > 1.5 and not correctable (per the discretion of the physician) or who require continuous complete anticoagulation Bleeding diathesis Altered anatomy of the upper gastrointestinal tract due to surgery of esophagus, stomach and duodenum that might preclude endoscopic drainage Presence of ileus caused by peritoneal carcinomatosis, or expected to present within 30 days post procedure Intervening gastric varices or vessels at the target site of stent insertion Ascites that may interfere the safety of the index procedure Biliary tract obstruction requiring treatment at the same day of the index procedure Allergic to any of the device materials Contraindications to use of electrosurgical devices Pregnancy, breastfeeding or intending to become pregnant during the study period Subject is currently participating, or plans to participate in, another investigational trial that may confound the results of this trial (unless written approval is received from the study sponsor) Vulnerable subject Subject has other reason not to be eligible for this study per investigators' discretion Guidewire doesn't cross the area of GOO EP-DB doesn't advance to the target site in jejunum The distance between the gastric wall and jejunal wall when visualized on ultrasound after saline is introduced into the space between the two inflated balloons of EP-DB is deemed about 2 cm or more
Sites / Locations
- Aichi Cancer Center HospitalRecruiting
- Teine Keijinkai HospitalRecruiting
- Saitama Medical University International Medical CenterRecruiting
- The University of Tokyo HospitalRecruiting
- Cancer Institute Hospital of JFCRRecruiting
- Tokyo Medical University HospitalRecruiting
Arms of the Study
Arm 1
Experimental
Hot AXIOS system
Hot AXIOS system (20 mm diameter stent)